Vaxcyte, Inc. - Common Stock (PCVX)

Vaxcyte Inc is a biotechnology company focused on developing innovative vaccines to address significant infectious diseases

The company's research and development efforts center on utilizing its proprietary technology platform to design and produce a new generation of polysaccharide-based vaccines. By targeting a range of pathogens, Vaxcyte aims to enhance immune response and provide effective prevention measures against diseases that disproportionately affect public health. Through its work, the company seeks to contribute to a healthier global population by advancing the science of vaccinology.